Prior Auth Required
0364U - disease burden, when appropriate
This procedure appears on the selected insurer prior authorization source.
Prior authorizationPrior Auth Required
Procedure / Servicedisease burden, when appropriate
Procedure / Service Description
Optical coherence tomography of breast or axillary lymph node, excised tissue, each - next-generation sequencing with algorithm, quantification of dominant clonal sequence(s), reported as presence or absence of minimal residual disease (MRD) with quantitation of 0364U disease burden, when appropriate Oncology (colorectal cancer), evaluation for mutations of APC, BRAF, CTNNB1, KRAS, NRAS, PIK3CA, SMAD4, and TP53, and methylation markers (MYO1G, KCNQ5, C9ORF50, FLI1, CLIP4,
Likely documents
- Confirm benefit details
- Submit clinical notes if requested by the plan
Next actions
- Confirm the current plan policy before submission.
- Use the insurer authorization workflow for this listed code.